IRIS
CRISCUOLO, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.709
NA - Nord America 1.620
AS - Asia 1.368
SA - Sud America 373
Continente sconosciuto - Info sul continente non disponibili 181
AF - Africa 42
OC - Oceania 3
Totale 5.296
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.535
RU - Federazione Russa 903
CN - Cina 465
SG - Singapore 412
BR - Brasile 305
IT - Italia 280
SE - Svezia 203
VN - Vietnam 181
HK - Hong Kong 146
DE - Germania 88
FR - Francia 61
CA - Canada 46
IN - India 39
FI - Finlandia 37
GB - Regno Unito 35
BD - Bangladesh 32
MX - Messico 25
PL - Polonia 25
AR - Argentina 23
EC - Ecuador 21
NL - Olanda 21
ZA - Sudafrica 19
JP - Giappone 17
ES - Italia 14
TR - Turchia 12
AT - Austria 10
IE - Irlanda 10
IQ - Iraq 9
ID - Indonesia 8
CO - Colombia 7
LT - Lituania 7
AE - Emirati Arabi Uniti 6
MY - Malesia 6
UZ - Uzbekistan 6
CL - Cile 5
JO - Giordania 5
MA - Marocco 5
PH - Filippine 5
UA - Ucraina 5
CR - Costa Rica 4
PK - Pakistan 4
SA - Arabia Saudita 4
AU - Australia 3
CM - Camerun 3
EG - Egitto 3
JM - Giamaica 3
KE - Kenya 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
A1 - Anonimo 2
BE - Belgio 2
BH - Bahrain 2
DK - Danimarca 2
DZ - Algeria 2
KR - Corea 2
NP - Nepal 2
RS - Serbia 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GY - Guiana 1
HN - Honduras 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SN - Senegal 1
SR - Suriname 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 5.118
Salva come PNG Salva come JPEG
Città #
Dallas 282
Ashburn 225
Singapore 212
Moscow 201
Hong Kong 144
Milan 123
San Jose 120
Beijing 97
Shanghai 88
Ho Chi Minh City 77
New York 61
Council Bluffs 56
Hefei 52
Los Angeles 45
Lauterbourg 42
Princeton 39
Lawrence 38
São Paulo 35
Santa Clara 33
Hanoi 28
Rome 27
Helsinki 26
Munich 26
Brescia 23
Warsaw 20
Atlanta 17
Montreal 17
Orem 16
Falkenstein 15
Nuremberg 15
Stockholm 15
Chennai 14
Denver 14
Johannesburg 14
Tokyo 14
Haiphong 12
Brooklyn 11
Cesano Boscone 11
The Dalles 11
Toronto 11
Boston 10
Dublin 10
Frankfurt am Main 10
Amsterdam 9
Bologna 9
Phoenix 9
Poplar 9
Belo Horizonte 8
Guangzhou 8
Houston 8
Mexico City 8
Porto Alegre 8
Turin 8
Chicago 7
London 7
Rio de Janeiro 7
Vienna 7
Guayaquil 6
Lappeenranta 6
The Bronx 6
Washington 6
Boardman 5
Columbus 5
Manaus 5
Naples 5
Quito 5
Salvador 5
San Francisco 5
Seattle 5
Shenzhen 5
Tashkent 5
Tianjin 5
Amman 4
Ancona 4
Ankara 4
Barnet 4
Campinas 4
Caxias do Sul 4
Charlotte 4
Curitiba 4
Da Nang 4
Florianópolis 4
Hangzhou 4
Hải Dương 4
Kuala Lumpur 4
Las Vegas 4
Manchester 4
New Delhi 4
Pittsburgh 4
Pune 4
Riyadh 4
San José 4
Sorocaba 4
South San Francisco 4
Turku 4
Antakya 3
Baghdad 3
Bergamo 3
Biên Hòa 3
Bogotá 3
Totale 2.655
Salva come PNG Salva come JPEG
Nome #
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 230
Evaluation of respiratory virus transmissibility and resilience from fomites: the case of 11 SARS-CoV-2 clinical isolates 199
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 174
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 147
The interferon landscape along the respiratory tract impacts the severity of COVID-19 142
Alternative methods of vaccine delivery: An overview of edible and intradermal vaccines 137
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 135
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 132
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 131
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 130
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells 128
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 127
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 127
Bacteriophages and Their Immunological Applications against Infectious Threats 111
The initial interplay between HIV and mucosal innate immunity 108
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement 107
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 107
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 105
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 105
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 104
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 104
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 101
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 99
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 99
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 94
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 93
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 91
Editorial: Viral escape of mucosal immunity in sexually transmitted diseases 90
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 88
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 87
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 86
Evaluation of synergistic interactions of anti-HCV/E2 monoclonal antibodies 86
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity 86
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 85
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 84
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 84
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies 82
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 81
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides. 80
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 80
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 80
Role and potential therapeutic use of antibodies against herpetic infections 79
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses 78
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 78
Viral Respiratory Pathogens and Lung Injury 73
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 72
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 69
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 60
Tracking remyelination in a model of multiple sclerosis: Visual evoked potentials reveal therapeutic effect from brain stimulation and exercise 54
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 51
Next Generation Vaccines for Infectious Diseases 50
Phage Therapy: An Alternative to Antibiotics 49
An Exploratory Survey on the Use of Anal Cytology as a Tool for Anal Cancer Screening in Italy 17
Long-Term Stability Bio-Reconfigurable Differential Impedance Electronic Platform for Virus Diagnostic 8
A humoral dilemma: reassessing monkeypox virus neutralizing antibodies at more than two years from Mpox or MVA-BN vaccination 6
miR-29a and miR-15b Modulate SARS-CoV-2 Beta and Omicron Infection in Human Lung Epithelial Cells 5
null 1
Totale 5.296
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.249
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202278 0 3 10 10 13 7 9 2 2 9 0 13
2022/2023356 89 78 49 7 3 41 33 30 15 2 8 1
2023/2024315 1 20 42 62 19 62 9 25 13 8 18 36
2024/2025892 81 20 13 35 33 94 158 170 90 63 58 77
2025/20263.259 233 279 373 423 305 96 259 229 779 136 69 78
2026/2027322 191 131 0 0 0 0 0 0 0 0 0 0
Totale 5.296